Skip to main content
. 2019 Dec 22;9(1):35. doi: 10.3390/jcm9010035

Figure 1.

Figure 1

RRMS in-patients who were treated at the study site between January 2013 and December 2017 are described here. The data focus on those patients who received a full course of intravenous methyl prednisolone (5 × 1 g IVMPS) as the first escalation treatment after relapse. Patients who received a lower dosage (e.g., 3 × 1 g IVMPS) were excluded from the primary analysis.